APO Research
Talk to an analyst

APO RESEARCH · REPORT

Adult and Adolescent Vaccines

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Adult and Adolescent Vaccines Industry Growth and Trends Forecast to 2032

22 December 202590 pages

Choose your research edition.

Industry ResearchAdult and Adolescent Vaccines Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Adult and Adolescent Vaccines Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal Adult and Adolescent Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Adult and Adolescent Vaccines Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Adult and Adolescent Vaccines Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Adult and Adolescent Vaccines market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Adult and Adolescent Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Adult and Adolescent Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Adult and Adolescent Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Adult and Adolescent Vaccines include Novartis, Merck, Pfizer, GlaxoSmithKline and Sanofi Aventis, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Adult and Adolescent Vaccines market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Adult and Adolescent Vaccines market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Adult and Adolescent Vaccines market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Adult and Adolescent Vaccines.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Adult and Adolescent Vaccines market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Adult and Adolescent Vaccines Market by Company

Novartis

Merck

Pfizer

GlaxoSmithKline

Sanofi Aventis

Adult and Adolescent Vaccines Segment by Type

Seasonal Vaccines

Travel Vaccines

Adult and Adolescent Vaccines Segment by Application

Adult

Adolescent

Adult and Adolescent Vaccines Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Adult and Adolescent Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Adult and Adolescent Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Adult and Adolescent Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Adult and Adolescent Vaccines manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Adult and Adolescent Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Seasonal Vaccines Table 2. Major Company of Travel Vaccines Table 3. Global Adult and Adolescent Vaccines Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Adult and Adolescent Vaccines Sales by Type (2021-2026) & (k units) Table 5. Global Adult and Adolescent Vaccines Sales Market Share in Volume by Type (2021-2026) Table 6. Global Adult and Adolescent Vaccines Sales by Type (2021-2026) & (US$ Million) Table 7. Global Adult and Adolescent Vaccines Sales Market Share in Value by Type (2021-2026) Table 8. Global Adult and Adolescent Vaccines Price by Type (2021-2026) & (US$/unit) Table 9. Global Adult and Adolescent Vaccines Sales by Type (2027-2032) & (k units) Table 10. Global Adult and Adolescent Vaccines Sales Market Share in Volume by Type (2027-2032) Table 11. Global Adult and Adolescent Vaccines Sales by Type (2027-2032) & (US$ Million) Table 12. Global Adult and Adolescent Vaccines Sales Market Share in Value by Type (2027-2032) Table 13. Global Adult and Adolescent Vaccines Price by Type (2027-2032) & (US$/unit) Table 14. North America Adult and Adolescent Vaccines Sales by Type (2021-2026) & (k units) Table 15. North America Adult and Adolescent Vaccines Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Adult and Adolescent Vaccines Sales by Type (2021-2026) & (k units) Table 17. Europe Adult and Adolescent Vaccines Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Adult and Adolescent Vaccines Sales by Type (2021-2026) & (k units) Table 19. Asia-Pacific Adult and Adolescent Vaccines Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Adult and Adolescent Vaccines Sales by Type (2021-2026) & (k units) Table 21. Latin America Adult and Adolescent Vaccines Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Adult and Adolescent Vaccines Sales by Type (2021-2026) & (k units) Table 23. Middle East and Africa Adult and Adolescent Vaccines Sales by Type (2021-2026) & (US$ Million) Table 24. Adult and Adolescent Vaccines Industry Trends Table 25. Adult and Adolescent Vaccines Industry Drivers Table 26. Adult and Adolescent Vaccines Industry Opportunities and Challenges Table 27. Adult and Adolescent Vaccines Industry Restraints Table 28. Global Adult and Adolescent Vaccines Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Adult and Adolescent Vaccines Revenue Market Share by Company (2021-2026) Table 30. Global Adult and Adolescent Vaccines Sales by Company (2021-2026) & (k units) Table 31. Global Adult and Adolescent Vaccines Sales Share by Company (2021-2026) Table 32. Global Adult and Adolescent Vaccines Market Price by Company (2021-2026) & (US$/unit) Table 33. Global Adult and Adolescent Vaccines Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Adult and Adolescent Vaccines Major Company Production Sites and Headquarters Table 35. Global Adult and Adolescent Vaccines Company, Product Type & Application Table 36. Global Adult and Adolescent Vaccines Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Adult and Adolescent Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Adult and Adolescent Vaccines Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Adult and Adolescent Vaccines Sales by Region (2021-2026) & (k units) Table 41. Global Adult and Adolescent Vaccines Sales Market Share in Volume by Region (2021-2026) Table 42. Global Adult and Adolescent Vaccines Sales by Region (2021-2026) & (US$ Million) Table 43. Global Adult and Adolescent Vaccines Sales Market Share in Value by Region (2021-2026) Table 44. Global Adult and Adolescent Vaccines Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 45. Global Adult and Adolescent Vaccines Sales by Region (2027-2032) & (k units) Table 46. Global Adult and Adolescent Vaccines Sales Market Share in Volume by Region (2027-2032) Table 47. Global Adult and Adolescent Vaccines Sales by Region (2027-2032) & (US$ Million) Table 48. Global Adult and Adolescent Vaccines Sales Market Share in Value by Region (2027-2032) Table 49. Global Adult and Adolescent Vaccines Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 50. Global Adult and Adolescent Vaccines Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Adult and Adolescent Vaccines Sales by Application (2021-2026) & (k units) Table 52. Global Adult and Adolescent Vaccines Sales Market Share in Volume by Application (2021-2026) Table 53. Global Adult and Adolescent Vaccines Sales by Application (2021-2026) & (US$ Million) Table 54. Global Adult and Adolescent Vaccines Sales Market Share in Value by Application (2021-2026) Table 55. Global Adult and Adolescent Vaccines Price by Application (2021-2026) & (US$/unit) Table 56. Global Adult and Adolescent Vaccines Sales by Application (2027-2032) & (k units) Table 57. Global Adult and Adolescent Vaccines Sales Market Share in Volume by Application (2027-2032) Table 58. Global Adult and Adolescent Vaccines Sales by Application (2027-2032) & (US$ Million) Table 59. Global Adult and Adolescent Vaccines Sales Market Share in Value by Application (2027-2032) Table 60. Global Adult and Adolescent Vaccines Price by Application (2027-2032) & (US$/unit) Table 61. North America Adult and Adolescent Vaccines Sales by Application (2021-2026) & (k units) Table 62. North America Adult and Adolescent Vaccines Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Adult and Adolescent Vaccines Sales by Application (2021-2026) & (k units) Table 64. Europe Adult and Adolescent Vaccines Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Adult and Adolescent Vaccines Sales by Application (2021-2026) & (k units) Table 66. Asia-Pacific Adult and Adolescent Vaccines Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Adult and Adolescent Vaccines Sales by Application (2021-2026) & (k units) Table 68. Latin America Adult and Adolescent Vaccines Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Adult and Adolescent Vaccines Sales by Application (2021-2026) & (k units) Table 70. Middle East and Africa Adult and Adolescent Vaccines Sales by Application (2021-2026) & (US$ Million) Table 71. Novartis Company Information Table 72. Novartis Business Overview Table 73. Novartis Adult and Adolescent Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Novartis Adult and Adolescent Vaccines Product Portfolio Table 75. Novartis Recent Development Table 76. Merck Company Information Table 77. Merck Business Overview Table 78. Merck Adult and Adolescent Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Merck Adult and Adolescent Vaccines Product Portfolio Table 80. Merck Recent Development Table 81. Pfizer Company Information Table 82. Pfizer Business Overview Table 83. Pfizer Adult and Adolescent Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. Pfizer Adult and Adolescent Vaccines Product Portfolio Table 85. Pfizer Recent Development Table 86. GlaxoSmithKline Company Information Table 87. GlaxoSmithKline Business Overview Table 88. GlaxoSmithKline Adult and Adolescent Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. GlaxoSmithKline Adult and Adolescent Vaccines Product Portfolio Table 90. GlaxoSmithKline Recent Development Table 91. Sanofi Aventis Company Information Table 92. Sanofi Aventis Business Overview Table 93. Sanofi Aventis Adult and Adolescent Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. Sanofi Aventis Adult and Adolescent Vaccines Product Portfolio Table 95. Sanofi Aventis Recent Development Table 96. North America Adult and Adolescent Vaccines Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 97. North America Adult and Adolescent Vaccines Sales by Country (2021-2026) & (k units) Table 98. North America Adult and Adolescent Vaccines Sales Market Share by Country (2021-2026) Table 99. North America Adult and Adolescent Vaccines Sales Forecast by Country (2027-2032) & (k units) Table 100. North America Adult and Adolescent Vaccines Sales Market Share Forecast by Country (2027-2032) Table 101. North America Adult and Adolescent Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 102. North America Adult and Adolescent Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 103. North America Adult and Adolescent Vaccines Market Share by Country (2021-2026) Table 104. North America Adult and Adolescent Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 105. North America Adult and Adolescent Vaccines Market Share Forecast by Country (2027-2032) Table 106. Europe Adult and Adolescent Vaccines Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 107. Europe Adult and Adolescent Vaccines Sales by Country (2021-2026) & (k units) Table 108. Europe Adult and Adolescent Vaccines Sales Market Share by Country (2021-2026) Table 109. Europe Adult and Adolescent Vaccines Sales Forecast by Country (2027-2032) & (k units) Table 110. Europe Adult and Adolescent Vaccines Sales Market Share Forecast by Country (2027-2032) Table 111. Europe Adult and Adolescent Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 112. Europe Adult and Adolescent Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 113. Europe Adult and Adolescent Vaccines Market Share by Country (2021-2026) Table 114. Europe Adult and Adolescent Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 115. Europe Adult and Adolescent Vaccines Market Share Forecast by Country (2027-2032) Table 116. Asia-Pacific Adult and Adolescent Vaccines Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 117. Asia-Pacific Adult and Adolescent Vaccines Sales by Country (2021-2026) & (k units) Table 118. Asia-Pacific Adult and Adolescent Vaccines Sales Market Share by Country (2021-2026) Table 119. Asia-Pacific Adult and Adolescent Vaccines Sales Forecast by Country (2027-2032) & (k units) Table 120. Asia-Pacific Adult and Adolescent Vaccines Sales Market Share Forecast by Country (2027-2032) Table 121. Asia-Pacific Adult and Adolescent Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. Asia-Pacific Adult and Adolescent Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 123. Asia-Pacific Adult and Adolescent Vaccines Market Share by Country (2021-2026) Table 124. Asia-Pacific Adult and Adolescent Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. Asia-Pacific Adult and Adolescent Vaccines Market Share Forecast by Country (2027-2032) Table 126. Latin America Adult and Adolescent Vaccines Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 127. Latin America Adult and Adolescent Vaccines Sales by Country (2021-2026) & (k units) Table 128. Latin America Adult and Adolescent Vaccines Sales Market Share by Country (2021-2026) Table 129. Latin America Adult and Adolescent Vaccines Sales Forecast by Country (2027-2032) & (k units) Table 130. Latin America Adult and Adolescent Vaccines Sales Market Share Forecast by Country (2027-2032) Table 131. Latin America Adult and Adolescent Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. Latin America Adult and Adolescent Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 133. Latin America Adult and Adolescent Vaccines Market Share by Country (2021-2026) Table 134. Latin America Adult and Adolescent Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. Latin America Adult and Adolescent Vaccines Market Share Forecast by Country (2027-2032) Table 136. Middle East and Africa Adult and Adolescent Vaccines Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 137. Middle East and Africa Adult and Adolescent Vaccines Sales by Country (2021-2026) & (k units) Table 138. Middle East and Africa Adult and Adolescent Vaccines Sales Market Share by Country (2021-2026) Table 139. Middle East and Africa Adult and Adolescent Vaccines Sales Forecast by Country (2027-2032) & (k units) Table 140. Middle East and Africa Adult and Adolescent Vaccines Sales Market Share Forecast by Country (2027-2032) Table 141. Middle East and Africa Adult and Adolescent Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Middle East and Africa Adult and Adolescent Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 143. Middle East and Africa Adult and Adolescent Vaccines Market Share by Country (2021-2026) Table 144. Middle East and Africa Adult and Adolescent Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Middle East and Africa Adult and Adolescent Vaccines Market Share Forecast by Country (2027-2032) Table 146. Key Raw Materials Table 147. Raw Materials Key Suppliers Table 148. Adult and Adolescent Vaccines Distributors List Table 149. Adult and Adolescent Vaccines Customers List Table 150. Research Programs/Design for This Report Table 151. Authors List of This Report Table 152. Secondary Sources Table 153. Primary Sources List of Figures Figure 1. Adult and Adolescent Vaccines Image Figure 2. Global Adult and Adolescent Vaccines Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Adult and Adolescent Vaccines Market Size (2021-2032) & (US$ Million) Figure 4. Global Adult and Adolescent Vaccines Sales (2021-2032) & (k units) Figure 5. Seasonal Vaccines Image Figure 6. Global Seasonal Vaccines Sales YoY Growth (2021-2032) & (k units) Figure 7. Travel Vaccines Image Figure 8. Global Travel Vaccines Sales YoY Growth (2021-2032) & (k units) Figure 9. Global Adult and Adolescent Vaccines Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Adult and Adolescent Vaccines Market Share by Type 2025 VS 2032 Figure 11. North America Adult and Adolescent Vaccines Sales Market Share in Volume by Type in 2025 Figure 12. North America Adult and Adolescent Vaccines Sales Market Share in Value by Type in 2025 Figure 13. Europe Adult and Adolescent Vaccines Sales Market Share in Volume by Type in 2025 Figure 14. Europe Adult and Adolescent Vaccines Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Adult and Adolescent Vaccines Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Adult and Adolescent Vaccines Sales Market Share in Value by Type in 2025 Figure 17. Latin America Adult and Adolescent Vaccines Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Adult and Adolescent Vaccines Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Adult and Adolescent Vaccines Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Adult and Adolescent Vaccines Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Adult and Adolescent Vaccines Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Adult Image Figure 24. Global Adult Sales YoY Growth (2021-2032) & (k units) Figure 25. Adolescent Image Figure 26. Global Adolescent Sales YoY Growth (2021-2032) & (k units) Figure 27. Global Adult and Adolescent Vaccines Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Adult and Adolescent Vaccines Market Share by Application 2025 VS 2032 Figure 29. North America Adult and Adolescent Vaccines Sales Market Share in Volume by Application in 2025 Figure 30. North America Adult and Adolescent Vaccines Sales Market Share in Value by Application in 2025 Figure 31. Europe Adult and Adolescent Vaccines Sales Market Share in Volume by Application in 2025 Figure 32. Europe Adult and Adolescent Vaccines Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Adult and Adolescent Vaccines Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Adult and Adolescent Vaccines Sales Market Share in Value by Application in 2025 Figure 35. Latin America Adult and Adolescent Vaccines Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Adult and Adolescent Vaccines Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Adult and Adolescent Vaccines Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Adult and Adolescent Vaccines Sales Market Share in Value by Application in 2025 Figure 39. North America Adult and Adolescent Vaccines Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 40. North America Adult and Adolescent Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Adult and Adolescent Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Adult and Adolescent Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Adult and Adolescent Vaccines Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 44. Europe Adult and Adolescent Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Adult and Adolescent Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Adult and Adolescent Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Adult and Adolescent Vaccines Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 48. Asia-Pacific Adult and Adolescent Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Adult and Adolescent Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Adult and Adolescent Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Adult and Adolescent Vaccines Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. Latin America Adult and Adolescent Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Adult and Adolescent Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Adult and Adolescent Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Adult and Adolescent Vaccines Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Middle East and Africa Adult and Adolescent Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Adult and Adolescent Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Adult and Adolescent Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Adult and Adolescent Vaccines Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Adult and Adolescent Vaccines Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Seasonal Vaccines
  • Travel Vaccines
Applications
  • Adult
  • Adolescent
Companies covered
  • Novartis
  • Merck
  • Pfizer
  • GlaxoSmithKline
  • Sanofi Aventis

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Adult and Adolescent Vaccines Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Adult and Adolescent Vaccines Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Adult and Adolescent Vaccines Market by Type
  6. 1.3.1 Seasonal Vaccines
  7. 1.3.2 Travel Vaccines
  8. 1.4 Global Adult and Adolescent Vaccines Market Size by Type
  9. 1.4.1 Global Adult and Adolescent Vaccines Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Adult and Adolescent Vaccines Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Adult and Adolescent Vaccines Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Adult and Adolescent Vaccines Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Adult and Adolescent Vaccines Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Adult and Adolescent Vaccines Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Adult and Adolescent Vaccines Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Adult and Adolescent Vaccines Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Adult and Adolescent Vaccines Industry Trends
  2. 2.2 Adult and Adolescent Vaccines Industry Drivers
  3. 2.3 Adult and Adolescent Vaccines Industry Opportunities and Challenges
  4. 2.4 Adult and Adolescent Vaccines Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Adult and Adolescent Vaccines Revenue (2021-2026)
  2. 3.2 Global Top Players by Adult and Adolescent Vaccines Sales (2021-2026)
  3. 3.3 Global Top Players by Adult and Adolescent Vaccines Price (2021-2026)
  4. 3.4 Global Adult and Adolescent Vaccines Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Adult and Adolescent Vaccines Major Company Production Sites & Headquarters
  6. 3.6 Global Adult and Adolescent Vaccines Company, Product Type & Application
  7. 3.7 Global Adult and Adolescent Vaccines Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Adult and Adolescent Vaccines Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Adult and Adolescent Vaccines Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Adult and Adolescent Vaccines Tier 1, Tier 2, and Tier 3
4 Adult and Adolescent Vaccines Regional Status and Outlook
  1. 4.1 Global Adult and Adolescent Vaccines Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Adult and Adolescent Vaccines Historic Market Size by Region
  3. 4.2.1 Global Adult and Adolescent Vaccines Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Adult and Adolescent Vaccines Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Adult and Adolescent Vaccines Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Adult and Adolescent Vaccines Forecasted Market Size by Region
  7. 4.3.1 Global Adult and Adolescent Vaccines Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Adult and Adolescent Vaccines Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Adult and Adolescent Vaccines Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Adult and Adolescent Vaccines by Application
  1. 5.1 Adult and Adolescent Vaccines Market by Application
  2. 5.1.1 Adult
  3. 5.1.2 Adolescent
  4. 5.2 Global Adult and Adolescent Vaccines Market Size by Application
  5. 5.2.1 Global Adult and Adolescent Vaccines Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Adult and Adolescent Vaccines Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Adult and Adolescent Vaccines Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Adult and Adolescent Vaccines Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Adult and Adolescent Vaccines Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Adult and Adolescent Vaccines Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Adult and Adolescent Vaccines Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Adult and Adolescent Vaccines Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Novartis
  2. 6.1.1 Novartis Company Information
  3. 6.1.2 Novartis Business Overview
  4. 6.1.3 Novartis Adult and Adolescent Vaccines Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Novartis Adult and Adolescent Vaccines Product Portfolio
  6. 6.1.5 Novartis Recent Developments
  7. 6.2 Merck
  8. 6.2.1 Merck Company Information
  9. 6.2.2 Merck Business Overview
  10. 6.2.3 Merck Adult and Adolescent Vaccines Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Merck Adult and Adolescent Vaccines Product Portfolio
  12. 6.2.5 Merck Recent Developments
  13. 6.3 Pfizer
  14. 6.3.1 Pfizer Company Information
  15. 6.3.2 Pfizer Business Overview
  16. 6.3.3 Pfizer Adult and Adolescent Vaccines Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Pfizer Adult and Adolescent Vaccines Product Portfolio
  18. 6.3.5 Pfizer Recent Developments
  19. 6.4 GlaxoSmithKline
  20. 6.4.1 GlaxoSmithKline Company Information
  21. 6.4.2 GlaxoSmithKline Business Overview
  22. 6.4.3 GlaxoSmithKline Adult and Adolescent Vaccines Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 GlaxoSmithKline Adult and Adolescent Vaccines Product Portfolio
  24. 6.4.5 GlaxoSmithKline Recent Developments
  25. 6.5 Sanofi Aventis
  26. 6.5.1 Sanofi Aventis Company Information
  27. 6.5.2 Sanofi Aventis Business Overview
  28. 6.5.3 Sanofi Aventis Adult and Adolescent Vaccines Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Sanofi Aventis Adult and Adolescent Vaccines Product Portfolio
  30. 6.5.5 Sanofi Aventis Recent Developments
7 North America by Country
  1. 7.1 North America Adult and Adolescent Vaccines Sales by Country
  2. 7.1.1 North America Adult and Adolescent Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Adult and Adolescent Vaccines Sales by Country (2021-2026)
  4. 7.1.3 North America Adult and Adolescent Vaccines Sales Forecast by Country (2027-2032)
  5. 7.2 North America Adult and Adolescent Vaccines Market Size by Country
  6. 7.2.1 North America Adult and Adolescent Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Adult and Adolescent Vaccines Market Size by Country (2021-2026)
  8. 7.2.3 North America Adult and Adolescent Vaccines Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Adult and Adolescent Vaccines Sales by Country
  2. 8.1.1 Europe Adult and Adolescent Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Adult and Adolescent Vaccines Sales by Country (2021-2026)
  4. 8.1.3 Europe Adult and Adolescent Vaccines Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Adult and Adolescent Vaccines Market Size by Country
  6. 8.2.1 Europe Adult and Adolescent Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Adult and Adolescent Vaccines Market Size by Country (2021-2026)
  8. 8.2.3 Europe Adult and Adolescent Vaccines Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Adult and Adolescent Vaccines Sales by Country
  2. 9.1.1 Asia-Pacific Adult and Adolescent Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Adult and Adolescent Vaccines Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Adult and Adolescent Vaccines Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Adult and Adolescent Vaccines Market Size by Country
  6. 9.2.1 Asia-Pacific Adult and Adolescent Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Adult and Adolescent Vaccines Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Adult and Adolescent Vaccines Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Adult and Adolescent Vaccines Sales by Country
  2. 10.1.1 South America Adult and Adolescent Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Adult and Adolescent Vaccines Sales by Country (2021-2026)
  4. 10.1.3 South America Adult and Adolescent Vaccines Sales Forecast by Country (2027-2032)
  5. 10.2 South America Adult and Adolescent Vaccines Market Size by Country
  6. 10.2.1 South America Adult and Adolescent Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Adult and Adolescent Vaccines Market Size by Country (2021-2026)
  8. 10.2.3 South America Adult and Adolescent Vaccines Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Adult and Adolescent Vaccines Sales by Country
  2. 11.1.1 Middle East and Africa Adult and Adolescent Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Adult and Adolescent Vaccines Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Adult and Adolescent Vaccines Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Adult and Adolescent Vaccines Market Size by Country
  6. 11.2.1 Middle East and Africa Adult and Adolescent Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Adult and Adolescent Vaccines Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Adult and Adolescent Vaccines Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Adult and Adolescent Vaccines Value Chain Analysis
  2. 12.1.1 Adult and Adolescent Vaccines Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Adult and Adolescent Vaccines Production Mode & Process
  7. 12.2 Adult and Adolescent Vaccines Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Adult and Adolescent Vaccines Distributors
  10. 12.2.3 Adult and Adolescent Vaccines Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst